Abstract Purpose: To compare the sensitivities of MRI, FDG-PET and ictal/SPECT in localization of the epileptogenic substrate in patients with refractory temporal lobe epilepsy. This study included 137 patients who received surgical treatment for intractable epilepsy. MRI, FDGPET and ictal 99m Tc-HMPAO SPECT were retrospectively reviewed regarding their sensitivity in lateralization of the epileptogenic zone compared to video/EEG, pathological results and surgical outcome.
Introduction
Surgery for treatment of epilepsy has emerged as a worldwide established option for treatment of patients with seizure that is refractory to antiepileptic drug management. In patients with refractory epilepsy, neuroimaging is crucial for precisely identifying epileptogenic foci that are potentially amenable to surgical resection for possible cure (1) . Electroencephalogram (EEG) remains the most powerful tool for delineating the epileptogenic zone and is the primary tool in the selection and evaluation of presurgical candidates at most institutions (2) . In the clinical setting, structural MR imaging remains the fundamental neuroimaging technique for identifying a lesion that could be responsible for the epilepsy (3) . Functional radionuclide imaging including PET and ictal SPECT or advanced magnetic resonance imaging techniques can provide complementary information when an epileptogenic substrate is not identified or in the presence of non-concordant clinical and structural findings (4) .
The objective of this study is to compare the sensitivity of MR imaging, FDG-PET, and ictal 99m Tc-HMPAO SPECT in pre-operative localization of the epileptogenic zone in patients with refractory temporal lobe epilepsy in both pediatric and adult patient groups using video/EEG and pathological findings as standards of reference. We also compared the relationship between the concordance rates of these imaging modalities with the post-surgical outcome.
Patients and methods
Our study included 137 patients who received surgical treatment for their medically intractable epilepsy during the period from September 2006 through February 2011. The presurgical diagnosis of temporal lobe epilepsy was made by clinical history, seizure semiology and video/EEG monitoring and was pathologically confirmed after surgery. The patients were 86 males and 51 females with an age range at the time of surgery of 2 to 67 years (mean, 29 years).
Video EEG was recorded in the special epilepsy ward using a 24 hour video-monitoring system. Scalp EEG was recorded using an EEG cap utilizing the 10-20 electrode placement system. Data were recorded using a Nihon Kohden EEG machine. Ictal EEG changes, MRI, FDG-PET, and ictal 99m Tc-HMPAO SPECT were retrospectively reviewed regarding their sensitivity in localization of the affected zone.
Structural high-resolution MR imaging
Structural high-resolution MR imaging was performed using G.E signa LX 1.5T and GE signa HDxc 3.0T machines with standard head coil. Our protocol started with the examination of the whole brain using conventional spin-echo T1-weighted sagittal and axial images with axial FLAIR, DWI and T2-weighted images using 3 mm section thickness and 1 mm gap. Then dedicated sequences for the temporal lobes were obtained including coronal T1 3D SPGR, T2 IR, FLAIR and T2-weighted images perpendicular to the long axis of the hippocampus using 1.5 mm slice thickness sections. T1-weighted gadolinium-enhanced images were performed in selected cases such as tumors.
Positron emission tomography
PET was performed with an injection of 2-10 mCi of 18 F fluorodeoxyglucose (FDG) during the interictal period on a Gemini Philips time of flight scanner. Patients were either sedated if uncooperative or if cooperative asked to lie still with their eyes closed in a quiet dimly lit room. The patients were examined 30-40 min after injection. The acquisition time was 10-20 min. Axial and coronal images were reconstructed with a Shepp-Legon filter. The criterion of abnormality was the presence of asymmetrical temporal lobe decrease in FDG uptake (15% or more).
Ictal single photon emission CT
Ictal Technetium ( 99m Tc) Hexamethyl propyleneamine oxime (HMPAO) was performed using a dual-head Infinia Gamma camera GE Healthcare equipped with low-energy ultra highresolution (LEUHR) collimator. The radiopharmaceutical was injected intravenously within 30 s after the onset of seizure in a dose of 7.4-11.1 MBq/kg for children and 740 Mbq for adults. Data acquisition was started 30-90 min after the seizure activity ceased. Sixty-four views, each registered over 40 s were recorded in a 128 · 128 matrix with pixel size of 2.9 · 2.9 mm. Transaxial tomograms were reconstructed using a Butterworth filter generating coronal and sagittal slices. The in-plane resolution of the reconstructed images was 11 mm FWHM and section thickness was approximately 5-8 mm. For the ictal SPECT, the area of hyperperfusion relative to the remaining regions was considered as the epileptogenic zone.
Criteria for correct localization
Correct localization of the epileptogenic substrate was considered when the abnormal finding in MR imaging, PET or ictal SPECT matched the video/EEG results, the operative site and the location of histopathological abnormality. Correct lateralization by PET or ictal SPECT was also interpreted when the diffuse abnormality detected by these imaging methods was overlapped with the operative site.
Concordance was considered when MRI, PET, or ictal SPECT localized the epileptogenic zone in the same area of abnormality compared to each other and compared to video/ EEG, and histopathological findings. Non-concordance was considered when the abnormal finding detected by the imaging method was not matching compared with one another and with pathological findings.
All the patients were followed up for 12 months or more after surgery to assess the relationship between the concordance rates of each imaging modality and the post-surgical outcome. The concordance or non-concordance was determined according to whether the preoperative localization was matching the operative site or not. The Engel's four categories system was used to assess the post-surgical outcome (5) . It includes; Class I (seizure-free) indicates an absence of seizure activity since surgery, regardless of medication. Class II indicates rare seizures; that is, a few in a year. Class III indicates worthwhile improvement, meaning at least a 75% improvement in seizure frequency compared with preoperative status. Class IV denotes no worthwhile improvement. In our study, good post-surgical outcome was considered in patients who remained seizure-free or with few seizures for 12 months or more after surgery (Engel's class I and II).
Results
From the total 137 patients with temporal lobe epilepsy included in this study, 104 patients showed positive findings on MR-imaging (MR-positive group) and 33 cases showed no definite lesions on MR imaging (MR-negative group).
MR-positive group
This group included patients in whom preoperative MRI detected an apparent temporal lobe lesion whether the lesion is unilateral or bilateral and whether involving the mesial (hippocampus, parahippocampal gyrus and amygdala) or lateral (neocortex or lateral cortex) temporal lobe structures. The most numerous pathology was hippocampal sclerosis (65%). Developmental malformations including microdysgenesis and focal cortical dysplasia were the second most frequent pathology (16%). Epileptogenic tumors were found in 12% of cases of this group (dysembryoplastic neuroepithelial tumor (DNET), 5%, ganglioglioma, 4%, low grade astrocytoma, 3%). Gliosis (post-ischemic or post-traumatic) was the least frequent lesions (7%) found in this group.
Compared to video/EEG as a first standard of reference, MR imaging, PET and ictal SPECT were concordant in 72%, 85% and 73% of cases, respectively. The three modalities were concordant to each other and matching the abnormal video/EEG findings in 58% of cases ( Figs. 1 and 2 ). The nonconcordance among the three imaging methods was found in 42% of cases (Figs. 3 and 4). When using the pathological findings as a second standard of reference, MR imaging, PET and ictal SPECT correctly localized the epileptogenic substrate in 70%, 87% and 73% of cases, respectively.
The post-surgical outcome was considered the third standard of reference using the Engel's outcome classification system (5). Engel's class I (seizure-free for 12 months or more regardless of the medication) and class II (rare seizure; that is, few seizures in a year) were considered as a good outcome.
Of the MR-positive group, 78 patients (75%) had good outcome. MR imaging, PET and ictal SPECT correctly localized the lesions in 79%, 88% and 78% of cases, respectively. MRI, PET and ictal SPECT were concordant together in 60% of the cases of this subgroup (Table 1) . Coronal FLAIR and T2-weighted MR image showed small sized right hippocampus compared to the left one with hyperintensity and loss of the normal alternating gray and white matter internal architecture (arrows). After anterior temporal lobectomy, the pathological diagnosis was right hippocampal sclerosis. Engel's outcome was class I.
MR-negative group
This group included 33 patients (non-lesional group). The MR imaging was apparently normal reported by two neuroradiologists (Fig. 5) . The sensitivity of PET and ictal SPECT in localization of the epileptogenic zone was 82% and 58%, respectively compared to video/EEG whereas the two modalities were concordant to pathological diagnosis in 85% and 56% of cases, respectively. Twenty patients (60%) of this group had good surgical outcome. PET correctly lateralized the abnormality in 80% of the cases of this group versus 75% by ictal SPECT. The combination of both modalities increased sensitivity to 100% ( Table 2 ). The abnormalities apparently missed by MR imaging and their zone correctly depicted by PET and ictal SPECT were as follows: cortical dysplasia (n = 8), microdysgenesis (n = 19), hippocampal sclerosis (n = 3), and focal neuronal loss (n = 3).
Discussion
In the management of temporal lobe epilepsy, exact lateralization/localization of seizure focus with a noninvasive study is crucial, because surgical resection of the epileptogenic lesion results in good outcome (Engel class I or II) and a failure to lateralize the focus with noninvasive examination may lead to an invasive study or to additional surgery for placement of intracranial electrodes, which may have potential risks (6) . Electroencephalogram (EEG) remains after 80 years since its first conception by Hans Berger, the most powerful tool in our arsenal for delineating the epilepsy and is the primary tool in the selection and evaluation of presurgical candidates at most institutions (2). However clear focus localization, especially in temporomesial structures of patients with TLE, is still a difficult task in which extensive video EEG monitoring is successful in 60-90% of cases (7).
Functional and structural neuroimaging techniques are increasingly indispensable in the evaluation of epileptic patients for localization of the epileptic area as well as for understanding pathophysiology, propagation, and neurochemical correlates of chronic epilepsy (8) .
MR imaging remains the method of choice for depicting gross structural lesions in the brain. However in our study even when using state-of-the-art protocols and using high resolution 3.0T machine in some cases, 24% of cases (33/137) remained without apparent lesion on MRI (MR-negative group). Although this ratio is less than other previous studies (9), it is still significant. In the cases where MRI shows no obvious lesions, PET and SPECT play a complementary role in the localization or lateralization of the epileptogenic focus and minimize the need for invasive EEG monitoring.
Only few studies comparing MRI, PET, and ictal SPECT in localizing the epileptogenic foci have been reported (8, 10, 11) , presumably due to the limited availability of these techniques. To our knowledge, no recent study has been published comparing these modalities in the temporal lobe substrate detection after the technical advancement of the three modalities and no recent reports available compared the 3.0T MR images with PET and ictal SPECT as regards the epileptogenic temporal zone detection.
Spencer (8) in his review of temporal lobe epilepsy found that the highest sensitivity was obtained with ictal SPECT (90%), the lowest sensitivity with MR imaging (55%) and intermediate sensitivity with PET (84%) when he used EEG as a standard of reference. However the technical advancement since the study conducted by Spencer has improved the detection rate of pathological lesions. In our study, the overall correct localization rate of the epileptogenic substrate was 72% with MR imaging, 85% with PET, and 73% by ictal SPECT. This means that the highest sensitivity was achieved by PET whereas ictal SPECT and MRI were nearly comparable. This was also reported by Hyung et al. (10) who found that PET showed the highest sensitivity for detection of both temporal and extratemporal epileptogenic lesions.
Good outcomes (Engel's class I and II) after surgery for temporal lobe epilepsy have been reported in approximately 70% to 90% of cases (12, 13) . In the present study, the correct localization rate of MR imaging in patients with good postsurgical outcome (79%) was higher than that for the total patients compared to video/EEG (72%). In those patients with favorable postsurgical outcome, PET detected the hypometabolism zone in 88% of cases compared to the area of hyperperfusion correctly localized by ictal SPECT in 87% of cases. In patients with normal MRI (MR-negative group) who had good surgical outcomes, the correct localization rates of the seizure focus by PET (80%) and ictal SPECT (75%) remained good. These findings indicated that PET and ictal SPECT in temporal lobe epilepsy show relatively comparable correct localization rates regardless the lesion detected by MRI or not. However detection of the lesion by MR imaging is associated with a better surgical outcome. This reflects that focal abnormalities, such as tumors, are well revealed by MR imaging and can be completely removed. Therefore, outcomes associated with focal abnormalities such as tumors will be better than those associated with diffuse or multifocal abnormalities, such as neuronal migration disorder or gliosis, which cannot be resected entirely.
In our study, when MRI was compared to video/EEG in localization of the epileptogenic substrate, 72% concordance rate was found whereas the non-concordance rate was about 28%. The latter rate is considered significant and showed the necessity of using multiple imaging techniques in order to obtain accurate pre-surgical evaluation. The concordance rate of PET and ictal SPECT was 85%, and 73% of cases, respectively. The three modalities were concordant to each other and matching the abnormal video/EEG findings in 58% of cases. This means that on using the different imaging modalities in our study, the non-concordance rate remained high (42%). This ratio coincides with what has been reported by Hyung et. al (10) who found the non-concordance rate as much as 30-40% of their patients.
The discrepancies among the different imaging techniques may be explained by the fact that they measure different aspects of the epileptic process; that is, MR imaging depicts only gross anatomic alterations associated with epilepsy whereas PET displays the cerebral metabolism and ictal SPECT measures the cerebral perfusion (14) . MR imaging and PET have an advantage in visualizing the whole brain; they not only depict the lesion in the medial temporal lobe but can also show abnormalities in other regions, such as an asymmetric, small, ipsilateral mamillary body and fornix on MR images in a patient with hippocampal sclerosis (15) and an asymmetric hypometabolism of the thalamus on PET scans in a patient with mesial temporal lobe epilepsy (16) .
In seizure-onset focus detection, the anatomical/pathological definition of the organic lesion is the most obvious on MR images. PET has the unique ability to image cerebral metabolism but is virtually limited to the interictal state, because it takes approximately 1 hour for the radiotracer to enter the cells to be metabolized and to be distributed throughout the brain tissue. This time is too long to image the relatively short ictal state (10) . SPECT, on the other hand, is used to assess the cerebral blood flow changes not only in the interictal state but also during the ictal period, as the radiotracer injected during the ictal state is distributed throughout the brain tissue within 1 min and remains radioactive in the brain tissue after cessation of seizure activity without significant redistribution (17) . In patients with normal MR imaging, PET was superior to ictal SPECT in lateralizing the epileptogenic substrate (85% versus 58%) when video/EEG was used as a standard of refer- ence. The sensitivity of ictal SPECT in this group of patients is considered relatively low. This could be explained in our study by the relatively late injection of the radiotracer. The timing of injection of the radiotracer is very critical in ictal SPECT to detect the seizure-onset zone. If the radiotracer is injected late during the seizure or after the seizure is over, isoperfusion or even hypoperfusion may be seen in the responsible area (18) . Because the spread of ictal discharges to other areas of the brain may occur within seconds of seizure onset, the SPECT scan, even with injection approximately 1 min after the onset of a seizure, may not indicate the site of onset (10) . The sensitivity of MRI, PET and ictal SPECT in epileptogenic zone detection (72%, 85%, and 73%, respectively) compared to video/EEG was relatively high in our study compared with some of the previous studies. In the series of Sung et al, (19) MR imaging, PET, and ictal SPECT localized the epileptogenic foci correctly in 60%, 78%, and 70% of patients, respectively. In Hyung et al. series (10) the sensitivity of the three modalities was 58%, 68%, and 58%.of cases, respectively. This discrepancy in sensitivity between those previous studies and our study is likely due to the technical advances of the imaging methods since these studies have been published particularly the technical maturation of using the 3.0T machine in cases of epilepsy which certainly improves the localization ability of MRI to the epileptogenic substrate.
Despite the use of high resolution MRI protocols and using the 3.0T machine, 24% of cases (33/137) showed no abnormal findings on MRI. Cortical dysplasia and microdysgenesis represented the majority of the pathological substrates missed by MRI in our study. These results reflect a relative insensitivity of MR imaging to neuronal migration disorder, especially in cases of mild dysplasia. Patients with mild to moderate dysplasia have a tendency to show subtle or unremarkable findings on MRI (20) . In these mild degree lesions, PET was more sensitive than ictal SPECT in localizing the seizure-onset zone (85% versus 56% compared to pathology). These results are also consistent with a previous review of literature describing that half the patients with normal MR imaging in cases of neuronal migration disorder had abnormal PET and SPECT findings (21) . These findings suggest the role of PET and ictal SPECT as complementary tools to MR imaging in cases with negative MR imaging findings.
Precise localization and removal of the epileptogenic focus is the ultimate treatment goal in patients with refractory temporal lobe epilepsy. Ideally, the probability of cutting the primary seizure focus out of the brain must approach 100% before an irreversible lobectomy is performed. However, until now, no single diagnostic test has proved sufficient in localizing the site to be surgically resected (19) .
So far, no single technique appears clearly superior overall to any of the others. Combination of localizing tests supporting clinical and scalp EEG findings should allow more patients to skip, for example, invasive intracranial EEG (22) .
In our opinion, if the MRI detects definite unilateral epileptogenic abnormality, PET and ictal SPECT will be further complementary diagnostic options for correct localization. If the three modalities are concordant to each other and matching with video EEG, our data suggest that no invasive subdural EEG is needed as it usually provides no additional information and at the same time carries the risk of an invasive procedure. On the other hand, if the MR imaging is normal (MR-non-lesional group) or if there is non-concordance between MRI and video/EEG, complementary functional studies by PET and ictal SPECT are indicated for the localization process. If the two imaging methods (PET and ictal SPECT) are concordant to each other and matching with video/EEG, no invasive intracranial EEG might be needed for localization information. But if the localization is still inconclusive and not adequate for precise surgery, or if there is still some discrepancy among the multiple techniques, an invasive study, usually with subdural electrodes, should be performed.
Conclusion
PET is the most sensitive method in lateralization of the epileptogenic zone. Although PET and ictal SPECT are more sensitive than MRI in lateralization of the epileptogenic lesions, the detection of abnormality by MRI is associated with good post-surgical outcome. The use of MRI, PET and ictal SPECT as a multimodality approach improves lateralization of the affected zone particularly in cases of negative MR finding and distinguish patients who will benefit from surgery.
